KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) EPS (Basic): 2016-2024

Historic EPS (Basic) for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to -$9.28.

  • Moderna's EPS (Basic) fell 1800.00% to -$0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.07, marking a year-over-year decrease of 38.90%. This contributed to the annual value of -$9.28 for FY2024, which is 24.74% up from last year.
  • According to the latest figures from FY2024, Moderna's EPS (Basic) is -$9.28, which was up 24.74% from -$12.33 recorded in FY2023.
  • In the past 5 years, Moderna's EPS (Basic) registered a high of $30.31 during FY2021, and its lowest value of -$12.33 during FY2023.
  • Its 3-year average for EPS (Basic) is -$0.12, with a median of -$9.28 in 2024.
  • As far as peak fluctuations go, Moderna's EPS (Basic) surged by 1,646.43% in 2021, and later crashed by 158.00% in 2023.
  • Moderna's EPS (Basic) (Yearly) stood at -$1.96 in 2020, then soared by 1,646.43% to $30.31 in 2021, then dropped by 29.86% to $21.26 in 2022, then plummeted by 158.00% to -$12.33 in 2023, then rose by 24.74% to -$9.28 in 2024.